Henry Schein Profile

69.51
USD 0.39  0.56%
66.5Last Month High 81.47 
67.85Trading Day  High 69.9 

Bona fide gift to Stanley Bergman of 360 shares of Henry Schein subject to Section 16

Henry Schein Inc insider trading alert for gift of common stock par value $0.01 per share by Stanley Bergman, Chairman CEO, on November 19, 2017. This event was filed by Henry Schein Inc with SEC on 2015-12-11. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Henry Schein Summary

Henry Schein Inc (HSIC) is traded on NASDAQ in USA. It is located in NEW YORK, U.S.A and employs 19,000 people. Henry Schein is listed under Wholesale category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with current market capitalization of 10.57 B. Henry Schein Inc conducts business under Healthcare sector and is part of Healthcare Products industry. This company has 158.11 M outstanding shares of which 1.55 M shares are currently shorted by private and institutional investors with about 5.11 trading days to cover. HENRY SCHEIN INC currently holds about 74.65 M in cash with 592.16 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47.
Check Henry Schein Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares16.3 M1.3 B
Fmr LlcCommon Shares13 M1.1 B
View Henry Schein Diagnostics

Selected Henry Schein Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Interest Expense    

Key Fundamentals

Henry Schein Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 1% 
Henry Schein, Inc. offer health care solutions and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. more
Fama & French Wholesale
Wholesale
Fama & French Classification
NameHenry Schein Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Healthcare Products
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationNEW YORK, U.S.A
Business Address135 Duryea Road, Melville, NY 11747, United States
Foreign Associate  UK
ExchangeNASDAQ
CIK Number01000228.0
ISINUS8064071025
CUSIP806407102
SectorHealthcare
IndustryHealthcare Products
BenchmarkDOW
Websitewww.henryschein.com
Contact Number631 843 5500
CurrencyUSD - US Dollar

Recommendations

Henry Schein Analyst Recommendations
Target PriceAdvice# of Analysts
177.14Buy7Odds
Henry Schein Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Henry Schein Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Henry Schein Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.66May 2, 2017
Henry Schein Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate